Seroprevalence, spatial distribution, and social determinants of SARS-CoV-2 in three urban centers of Chile

Abstract

Background Seroprevalence studies provide an accurate measure of SARS-CoV-2 spread and the presence of asymptomatic cases. They also provide information on the uneven impact of the pandemic, pointing out vulnerable groups to prioritize which is particularly relevant in unequal societies. However, due to their high cost, they provide limited evidence of spatial spread of the pandemic specially in unequal societies. Our objective was to estimate the prevalence of SARS-CoV-2 antibodies in Chile and model its spatial risk distribution. Methods During Oct–Nov 2020, we conducted a population-based serosurvey in Santiago, Talca, and Coquimbo–La Serena (2493 individuals). We explored the individual association between positive results and socio-economic and health-related variables by logistic regression for complex surveys. Then, using an Empirical Bayesian Kriging model, we estimated the infection risk spatial distribution using individual and census information, and compared these results with official records. Results Seroprevalence was 10.4% (95% CI 7.8–13.7%), ranging from 2% (Talca) to 11% (Santiago), almost three times the number officially reported. Approximately 36% of these were asymptomatic, reaching 82% below 15 years old. Seroprevalence was associated with the city of residence, previous COVID-19 diagnosis, contact with confirmed cases (especially at household), and foreign nationality. The spatial model accurately interpolated the distribution of disease risk within the cities finding significant differences in the predicted probabilities of SARS-CoV-2 infection by census zone (IQR 2.5–15.0%), related to population density and education. Conclusions Our results underscore the transmission heterogeneity of SARS-CoV-2 within and across three urban centers of Chile. Socio-economic factors and the outcomes of this seroprevalence study enable us to identify priority areas for intervention. Our methodological approach and results can help guide the design of interdisciplinary strategies for urban contexts, not only for SARS-CoV-2 but also for other communicable diseases.

Safety of International Professional Sports Competitions During the COVID-19 Pandemic: The Association Football Experience

“…To better understand the risks involved for local staff, and by extension the communities they live in, we analysed whether contagion in this group exceeded expectations (see ESM 3). Because direct comparison of incidence rates was not feasible due to Copa América’s compulsory testing programme, we established a baseline for contagion based on seroprevalence studies conducted at the time in Brazil [ 9 , 16 ]. Seroprevalence varied significantly with estimates for 2021 ranging from 17 to 35%, with large variations observed across the country [ 9 , 17 – 21 ] (see ESM 4).…”

Immunization and SARS-CoV-2 Antibody Seroprevalence in a Country with High Vaccination Coverage: Lessons from Chile

“…We performed a population-based cross-sectional serosurvey based on a previous study of a representative sample of the cities of Santiago, Coquimbo/La Serena, and Talca [ 7 ]. This study used a stratified sampling of three stages, census district, block, and dwelling for Coquimbo–La Serena and Talca, and municipality, block, and dwelling for the city of Santiago.…”

SARS-CoV-2 Neutralizing Antibodies in Chile after a Vaccination Campaign with Five Different Schemes

“…Serum neutralization capacity was measured using a pseudotyped vesicular stomatitis virus with a sequence encoding the enhanced green fluorescent protein as a reporter gene (VSV-GFP-Spike SARS-CoV-2 original Wuhan strain), kindly donated by Dr. Kartik Chandran [ 9 ]. Samples tested came from individuals enrolled in a population-based SARS-CoV-2 seroprevalence study performed by the same research team [ 10 , 11 , 12 ]. In November 2021, we collected 2198 serum samples from seven-year-old and older people, finding 97.3% of seropositivity.…”